This study aims to evaluate cardiovascular risk factors, clinical characteristics, and outcomes in adult patients attending an outpatient cardiology clinic. The research focuses on identifying predictors of adverse cardiovascular events, optimizing risk stratification, and improving preventive strategies in routine clinical practice. Data will be collected from patients receiving standard cardiology care without altering their treatment. The results are expected to contribute to better understanding of cardiovascular risk profiles and to support improvements in clinical decision-making and patient management.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
220
Protocol-based clinical management including periodic evaluation and adjustment of antihypertensive, lipid-lowering, antidiabetic, and lifestyle interventions according to routine clinical practice guidelines.
CDIEM Medical Center - Outpatient Cardiology Clinic
Santiago, Santiago Metropolitan, Chile
RECRUITINGChange in systolic blood pressure
Change in systolic blood pressure (mmHg) measured under standardized conditions to evaluate the effect of structured clinical and pharmacological cardiovascular risk management.
Time frame: Baseline to 90 days
Change in diastolic blood pressure
Evaluation of changes in diastolic blood pressure following structured clinical and pharmacological management.
Time frame: Baseline to 90 days
Change in LDL cholesterol
Evaluation of changes in LDL cholesterol measured during routine laboratory assessment after structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in HbA1c
Evaluation of changes in glycated hemoglobin (HbA1c) following structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in body weight
Evaluation of changes in body weight following lifestyle counseling and structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in renal function (eGFR)
Evaluation of changes in renal function assessed by estimated glomerular filtration rate following structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in HDL cholesterol
Evaluation of changes in HDL cholesterol measured during routine laboratory assessment after structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in triglycerides
Evaluation of changes in triglyceride levels measured during routine laboratory assessment after structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in total cholesterol
Evaluation of changes in total cholesterol measured during routine laboratory assessment after structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in fasting plasma glucose
Evaluation of changes in fasting plasma glucose following structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in body mass index
Evaluation of changes in body mass index following lifestyle counseling and structured cardiovascular risk management.
Time frame: Baseline to 90 days
Change in microalbuminuria
Evaluation of changes in urinary albumin excretion to assess microalbuminuria during follow-up after structured cardiovascular risk management.
Time frame: Baseline to 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.